Skip to main content
Premium Trial:

Request an Annual Quote

NIH Gives Illumina $9M to Help Study Common Diseases

NEW YORK, Oct. 1 - The US National Institutes of Health has given Illumina a $9 million award to perform "large-scale genotyping" studies and help the agency study a variety of "common" disorders, the company said yesterday.


Illumina said it will dispatch its Scientific Operations and Oligator oligo teams, which will apply the company's BeadArray technology to the NIH studies. The NIH hopes to get insight into diseases ranging from cancer to Alzheimer's.


Click here for more information.

The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.